Medication nonadherence is a growing issue for patients, clinicians, health care systems, and payers because of mounting evidence that it is prevalent and associated with adverse outcomes and higher costs of care. Here are some best practices to get people to take the medicines prescribed for them.
The specialty pharmacy community should remain alert in the coming months as the MEDCAC receives public comments and considers the future of Medicare coverage for 2 major therapies. The MEDCAC decision can have far-reaching impact on patient access.
Future strategies to manage specialty drugs are geared toward improving overall health care management of patients rather than relying on supply chain cost reduction strategies. The management of specialty drugs requires strategies that focus on outcomes and value.
What are some of the pitfalls that a pharmacy needs to avoid when setting up a relationship with a pharma manufacturer to accept authorizations from individuals to release information to that manufacturer?